FEB 10, 2021 11:10 AM PST

Ketamine Reduces Suicidal Thoughts in Patients with Depression

WRITTEN BY: Annie Lennon

Ketamine has been known for some time for its ability to tackle depression. Now, however, researchers have found that oral doses of the substance can significantly reduce suicidal ideation in patients with chronic suicidal thoughts as well. 

Most studies investigating the potential for ketamine against suicidality have been conducted on intravenous applications. While they show positive results, due to practical limitations of intravenous administration, researchers thought to see whether oral doses could offer benefits too.

As such, the researchers recruited 32 adults aged between 22 and 72, each with major depression and chronic suicidality- ongoing suicidal thoughts that linger in the mind over long periods. Each received 0.5mg of ketamine per kg of body weight, with doses gradually increasing to 3.0mg of ketamine per kg of body weight over a six week period. 

At the end of the six weeks, the researchers noted that 69% of patients went from a high level of suicidal ideation to under the clinical threshold. At a 4-week follow-up after the end of the trial, this figure decreased somewhat to 50% of participants. This means that while orally dosed ketamine seems effective in reducing suicidal thoughts, these positive effects seem to fade over time. The researchers nevertheless noted improvements in secondary measures of depression and suicidality.  

"To the best of our knowledge, the current study is the first to explore the feasibility, safety and tolerability of oral ketamine on chronic suicidality in patients who presented with a range of psychiatric conditions including mood, anxiety, and personality disorders," write the authors of the study.

"Overall, oral ketamine led to significant short-term and prolonged improvements in suicidal ideation, affective symptoms, well-being and socio-occupational functioning in this sample of adults with a history of chronic suicidality and [major depressive disorder]."

 

Sources: Science AlertNature

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 27, 2020
Genetics & Genomics
Delivering DNA- & RNA-Based Therapies in a New Way
DEC 27, 2020
Delivering DNA- & RNA-Based Therapies in a New Way
Gene therapy holds tremendous promise for its potential to cure genetic diseases. We've also recently seen how critical ...
JAN 13, 2021
Drug Discovery & Development
Could Rotten Egg Gas Reverse Alzheimer's?
JAN 13, 2021
Could Rotten Egg Gas Reverse Alzheimer's?
Researchers from Johns Hopkins University have found that hydrogen sulfide, a gas that smells like rotten eggs, may prot ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
MAR 21, 2021
Microbiology
Potent Drug Rapidly Clears Drug-Resistant Gonorrhea in Mouse Model
MAR 21, 2021
Potent Drug Rapidly Clears Drug-Resistant Gonorrhea in Mouse Model
A mouse model has shown that it's possible to clear a multi-drug resistant gonorrhea with only one dose of antibioti ...
APR 05, 2021
Drug Discovery & Development
Scientists Regenerate Missing Teeth in Mice
APR 05, 2021
Scientists Regenerate Missing Teeth in Mice
While most people have 32 teeth, around 1% of the population has more or fewer due to congenital reasons. Now, researche ...
APR 10, 2021
Drug Discovery & Development
How New ADHD Drug for Children Differs from Adderall
APR 10, 2021
How New ADHD Drug for Children Differs from Adderall
Over 1 in 10 children in the US aged between 5 and 17 have been diagnosed with attention deficit hyperactivity ...
Loading Comments...